Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Nadropar 2850IU Injection

Prescription Icon
Prescription Required

Marketer

Bharat Serums & Vaccines Ltd

Salt Composition

Nadroparin (2850IU)

Overview Nadropar 2850IU Injection

Nadropar 2850 IU Injection is an anti-clotting medication preventing and treating dangerous blood clots. It inhibits clot growth and formation in vital areas like the lungs, legs, heart, and brain. Administration is solely by a healthcare professional (doctor or nurse). Dosage and treatment duration depend on individual health, response to treatment, underlying condition, age, and weight. Continued injections are crucial, even without symptoms, to avert future complications; discontinuation risks clot formation. Potential side effects include bleeding, injection site reactions (including hematoma), and elevated liver enzymes. Patients should minimize bleeding risks by avoiding activities increasing injury potential (e.g., exercising caution with sharp objects). Prior to treatment, inform your doctor of conditions such as high blood pressure, diabetes, or recent stroke. Avoid use if actively bleeding. Medication interactions exist; disclose all other medications to your doctor. Consult your physician regarding Nadropar 2850 IU Injection use during pregnancy or breastfeeding.

Uses of Nadropar 2850IU Injection

Preventing and managing blood clots

Major Benefits of Nadropar 2850IU Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Nadropar 2850IU Injection:

  • Injection site reaction
  • Bleeding
  • Injection site hematoma
  • Increased liver enzymes

How to use Nadropar 2850IU Injection:

This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.

How Nadropar 2850IU Injection works:

Nadroparin 2850 IU injection acts as a blood thinner, inhibiting the development of potentially dangerous thrombi.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Nadropar 2850IU Injection may pose safety risks; medical advice is recommended.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Nadropar 2850IU Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Administering Nadropar 2850IU Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Nadropar 2850IU Injection's effect on driving ability is undetermined. Refrain from driving should you experience symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

For individuals with significant kidney impairment, administering Nadropar 2850IU Injection requires careful consideration. A modified dosage of Nadropar 2850IU Injection might be necessary. Physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding Nadropar 2850IU Injection's use in individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Nadropar 2850IU Injection :

Omit a Nadropar 2850IU Injection dose? Seek your physician's advice.

Facts to Know About Nadropar 2850IU Injection

LabelValue
Chemical Category Low-molecular-weight heparin
Developing Habits No.
Treatment Category KINSHIP
Action Category Low-molecular-weight heparin (LMWH)

FAQs on Nadropar 2850IU Injection

Before starting Nadropar 2850IU Injection, provide your doctor with a complete medical history. Disclose any existing conditions, including heart valve replacement, gastric ulcers, high blood pressure, diabetes, or kidney disease. Also mention any prior heparin reactions, recent strokes, or brain/spinal surgeries. These conditions may increase the risk of side effects. Strictly adhere to your doctor's instructions.
Use Nadropar 2850IU Injection only as prescribed by your doctor. Do not miss doses. Report any bothersome side effects to your physician.
Nadropar 2850IU Injection elevates your bleeding risk. Avoid activities that could cause injury or bleeding. Report any unusual bruising or bleeding to your doctor promptly.
Store Nadropar 2850IU Injection at 25°C; freezing is prohibited. Multiple-dose vials are stable for 28 days post-first use. Discard if particulate matter, discoloration, or syringe damage is observed. Consult the package leaflet; seek pharmacist advice if needed.
Nadropar 2850IU Injection treats chest pain and heart attack after standard treatment, typically alongside aspirin. Its blood-thinning action prevents clotting and reduces the risk of further complications.
Nadropar 2850IU Injection lowers your risk of blood clots in your legs, lungs, heart, and brain. You might not notice any immediate effects, but continue taking it as directed by your doctor to receive its full benefits.
Nadropar 2850IU Injection
186
MRP 215
13% off